News

The two companies believe that the agreement could make them significant market players in the oncology segment. The drug product is indicated for the treatment of advanced breast

The phase II trial will examine Davanat with Avastin, 5-Fluorouracil (5-FU) and Leucovorin in patients with locally advanced colorectal cancer who are unable to tolerate intensive chemotherapy with

According to Cenestra, Omax3 is the highest purity Omega 3 health supplement on the market, with each softgel containing 91% of pure Omega 3 content. The product is

“Since enrolling our first subject in September of this year, enrollment has proceeded rapidly, which we believe reflects the interest of our study investigators and clinicians in this

Biocon said that the drug could prove to be a multi-billion dollar opportunity for the company. “We are almost through with the phase II clinical trials of the

Patients receiving chemotherapy have often complained of problems with memory, problem-solving and other cognitive abilities. Although chemotherapy was thought not to affect brain cells due to the blood-brain

The study will evaluate the safety, tolerability and pharmacokinetics of single escalating doses of A-831 in healthy volunteers in the UK. A-831 targets the NS5a protein and is

Net income fell 35% from the $22.3 billion acquisition of Schering, but exceeded analysts expectations. According to Bayer, the acquired Schering business contributed E1.4 billion to sales in

Under the terms of the agreement, CytoPharm and its subsidiary will conduct all clinical trials, and seek to obtain regulatory approvals in both China and Taiwan to launch